Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.15 - $1.89 $3.79 Million - $6.24 Million
-3,300,000 Reduced 94.29%
200,000 $278,000
Q2 2022

Aug 15, 2022

BUY
$0.67 - $1.4 $2.35 Million - $4.9 Million
3,500,000 New
3,500,000 $4.59 Million
Q2 2020

Aug 14, 2020

SELL
$1.83 - $4.06 $8.41 Million - $18.7 Million
-4,597,701 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.32 - $2.47 $6.07 Million - $11.4 Million
4,597,701 New
4,597,701 $10.9 Million

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.